The agency issued its decision on Friday, giving the stamp of approval for Zepbound's use among adults with obesity for use in combination with a reduced-calorie diet ... FDA's Center for Drug ...

Tryngolza (olezarsen) has been approved by the U.S. Food and Drug ... with a diet including ≤20 g fat per day. Tryngolza is self-administered once monthly via an autoinjector. The FDA approval ...

In one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re both once-a-week injectable drugs designed to help ...

A non-opioid painkiller from Vertex Pharmaceuticals could become a blockbuster, but questions remain on whether it will prove ...

The first medication for obstructive sleep apnea has been approved ... The drug is to be paired with a reduced-calorie diet and increased physical activity, the FDA noted. Sally Seymour, M.D ...

It should be used with a reduced-calorie diet and ... the new FDA green light doesn’t expand the number of people who may be eligible for the drug, since the sleep apnea approval is specifically ...

The Food and Drug Administration on Friday approved ... which help people shave pounds. The FDA first approved Zepbound to treat obesity in November 2023. Its active ingredient, tirzepatide ...

The approval marks the second for a generic in this class of medications indicated to improve glycemic control in patients with type 2 diabetes as a complement to diet ... FDA’s Center for Drug ...

The US Food and Drug Administration has approved ... with type 2 diabetes (T2D), as an adjunct to diet and exercise. The move follows the FDA’s approval last month of a generic version of ...

23, 2024 -- The FDA has approved ... drug, Zepbound, for treating moderate to severe obstructive sleep apnea (OSA) in adults with obesity. Studies have shown that when combined with a low ...

The U.S. Food and Drug Administration (FDA) has granted approval for Zepbound ... The drug is designed to be used alongside a reduced-calorie diet and increased physical activity, offering ...